Stay updated on Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial

Sign up to get notified when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Publications section description updated to note items are automatically filled from PubMed and may not be about the study; the page revision tag updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:11:52.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removal of the general government funding status notice from the page footer; this administrative banner did not affect study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:38:30.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Screenshot comparison shows mostly identical study details with only minor UI/layout adjustments and timestamp updates. The core content (title, condition, interventions, and locations) appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T13:18:08.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Page now reflects a new revision (v3.2.0), adds a government-operating-status notice and a new AbbVie links section, and removes the old revision tag (v3.1.0).
    Difference
    5%
    Check dated 2025-10-06T04:16:17.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page update adds a new version label (v3.1.0) and removes several safety-related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and a link group (Helpful Links Provided by AbbVie clinical study report synopsis), indicating a simplification or de-emphasis of safety content in favor of newer versioning.
    Difference
    1%
    Check dated 2025-09-28T23:37:12.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page now shows revision v3.0.2 and adds a new 'Helpful Links Provided by AbbVie clinical study report synopsis' section, while removing the old v3.0.1 revision and the 'Back to Top' link.
    Difference
    0.8%
    Check dated 2025-09-14T09:49:24.000Z thumbnail image

Stay in the know with updates to Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Psoriasis in Russia Clinical Trial page.